Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs Omeprazole for H. pylori Eradication
NCT07040839Phase 4Not yet recruiting
- Sponsor
- Rehman Medical Institute
- Start
- Jul 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vonoprazan in Helicobacter pylori infection (4 arms), sponsored by Rehman Medical Institute. Primary endpoint: H. pylori Eradication Rate. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07040839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07040839.